Cytosorbents Crp
Price & Volume
Stats
See more52W Range | $3.58-$18.80 |
Market Cap | $11.9M |
Shares Short | 123,890 |
Financials
See moreRevenue (12 Mos) | $37.2M |
Revenue Growth (YoY) | 0.2% |
Gross Profit (12 Mos) | $26.6M |
Diluted EPS | -$5.80 |
News
See moreYahoo Finance • last month
CytoSorbents Announces New Real-World Data Demonstrating Significant Reduction in Severe Bleeding Using CytoSorb in CABG Patients on Ticagrelor and Updates Recent DrugSorb-ATR FDA Pre-Submission Meetings
Yahoo Finance • 4 months ago
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
Yahoo Finance • 5 months ago
Cytosorbents targets operating cash flow breakeven in 2H 2026 while planning DrugSorb-ATR de novo submission in late 2026/early 2027
Yahoo Finance • 11 months ago
Here are the major earnings after the close Thursday
About
CEO | Dr. Phillip P. Chan M.D., Ph.D. |
Address | 305 College Road East, Princeton, NJ, United States, 08540 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 129 |